These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8490550)

  • 1. Computer modelling in predicting carcinogenicity.
    Ioannides C; Lewis DF; Parke DV
    Eur J Cancer Prev; 1993 May; 2(3):275-82. PubMed ID: 8490550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of computers in the safety evaluation of drugs and other chemicals.
    Ioannides C; Lewis DF; Parke DV
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):225-33. PubMed ID: 7867665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1998 Jan; 412(1):41-54. PubMed ID: 9508363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing.
    Lewis DF; Ioannides C; Parke DV
    Environ Health Perspect; 1995 Feb; 103(2):178-84. PubMed ID: 7737067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of carcinogens and toxic chemicals.
    Parke DV; Ioannides C; Lewis DF
    Hum Toxicol; 1988 Sep; 7(5):397-404. PubMed ID: 3192223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals.
    Parke DV; Ioannides C; Lewis DF
    Can J Physiol Pharmacol; 1991 May; 69(5):537-49. PubMed ID: 1863904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer modelling and in vitro tests in the safety evaluation of chemicals-Strategic applications.
    Parke DV; Ioannides C; Lewis DF
    Toxicol In Vitro; 1990; 4(4-5):680-5. PubMed ID: 20702255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human carcinogens: an evaluation study via the COMPACT and HazardExpert procedures.
    Lewi DF; Bird MG; Jacobs MN
    Hum Exp Toxicol; 2002 Mar; 21(3):115-22. PubMed ID: 12102536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals.
    Fratev F; Benfenati E
    J Mol Graph Model; 2008 Sep; 27(2):147-60. PubMed ID: 18495507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of chemical carcinogenicity from molecular and electronic structures: a comparison of MINDO/3 and CNDO/2 molecular orbital methods.
    Lewis DF; Ioannides C; Parke DV
    Toxicol Lett; 1989 Jan; 45(1):1-13. PubMed ID: 2644723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How chemicals may induce cancer.
    Sarasin A; Meunier-Rotival M
    Biomedicine; 1976 Nov; 24(5):306-16. PubMed ID: 793643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective toxicity evaluation (COMPACT) on 40 chemicals currently being tested by the National Toxicology Program.
    Lewis DF; Ioannides C; Parke DV
    Mutagenesis; 1990 Sep; 5(5):433-5. PubMed ID: 2263201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies.
    Lewis DF; Ioannides C; Parke DV
    Hum Exp Toxicol; 1998 Oct; 17(10):577-86. PubMed ID: 9821022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1993 Feb; 291(1):61-77. PubMed ID: 7678916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.
    Elcombe CR; Odum J; Foster JR; Stone S; Hasmall S; Soames AR; Kimber I; Ashby J
    Environ Health Perspect; 2002 Apr; 110(4):363-75. PubMed ID: 11940454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.